Status:
COMPLETED
Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
Lead Sponsor:
Federal University of São Paulo
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
32 outpatients with a Posttraumatic Stress Disorder were included in a randomized comparative single-blind study to study the efficacy of aripiprazole to treat post-traumatic stress symptoms. The hyp...
Detailed Description
All patients which agreed to participate and signed the informed consent, were interviewed to be enrolled if they filled the inclusion and exclusion criteria. The inclusion criteria were: both gender...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PTSD (after SCID-I application by a trained psychiatrist).
- Use of an effective contraceptive method when the subject is women with sexual activity and with risk of pregnancy.
Exclusion
- Clinical diagnosis of schizophrenic, delusional, psychotic depression, schizoaffective, bipolar or borderline personality (after SCID-I application by the a trained psychiatrist).
- Clinical diagnosis of psychoactive substance dependence within 6-months before the study enrollment.
- To have decompensated medical diagnostics needing urgent treatment
- being pregnant.
- using psychoactive drugs.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00440713
Start Date
January 1 2004
End Date
March 1 2006
Last Update
February 27 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.